medigraphic.com

2004, Number 3

<< Back Next >>

Cir Cir 2004; 72 (3)

New therapeutics alternative in severe preeclampsia

Pardo-Morales RV, Romero-Figueroa S, Vázquez-de AGF, Briones-Garduño JC, Herrera-Villalobos JE, González-Vargas A

Language: Spanish
References: 23
Page: 203-207
PDF size: 51.11 Kb.


ABSTRACT

Introduction: Vasoconstriction is a major pathophysiologic finding in preeclampsia due to hyperactivity of the sympathetic nervous system and a consequent increase in concentration of plasmatic catecholamine. Thus, vasodilatation produced by secondary sympathetic block to lumbar epidural blockade favors control of high blood pressure in patients with severe preeclampsia. Objective: Our objective was to evaluate whether lumbar epidural blockade with bupivacaine 0.25% decreases high blood pressure of patients with severe preeclampsia within a lapse of 6 h in comparison with customary antihypertensive treatment. Material and methods: An open, randomized, controlled trial was carried out in 24 pregnant patients with 30 weeks of gestational age or more and diagnosis of severe preeclampsia who entered the Intensive Care Uni of the IMEIM Hospital of Gynecology and Obstetrics for hemodynamic stabilization and resolution of pregnancy. Group 1 (n = 12) was managed with customary antihypertensive treatment and group 2 (n = 12), with lumbar epidural blockade and bupivacaine 0.25%: 10 mg in bolus and 5 mg/h continuous epidural infusion. Patients were monitored non-invasively and with continuous clinical monitoring with MAP, SAP, and DAP during 6 h. Statistical analysis employed consisted of ANOVA measurement repeats. Results: In MAP and SAP, there were no significant differences between the two groups; DAP in first and second h of treatment had significant differences between the two groups (p value of ≤ 0.05). Conclusions: Lumbar epidural blockade with bupivacaine 0.25% can be used as a therapeutic alternative in high blood pressure control in patients with severe preeclampsia during the the first 6 h of hemodynamic stabilization.


REFERENCES

  1. Briones JC, Castañón JA, Díaz de León M, Briones CG. Velocidad de flujo sanguíneo cerebral en la preeclampsia-eclampsia. Prog Obstet Gynecol 2000;43:511-520.

  2. Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol 1995;22(11):781-791.

  3. Graeff H, von Hugo R, Schrock R. Recent aspects of hemostasis, hematology and hemorrheology in preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1994;17(2-3):91-102.

  4. Xiong X, Mayes D, Demianczuk N, Olson DM, Davidge ST, Newburn C, Saunders LD. Impact of pregnancy-induced hypertension on fetal growth. Am J Obst Gynecol 1999;180(January):1.

  5. Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Is J Obstet Gynecol 1993;169:1112-1118.

  6. Gómez-Gómez M, Cruz-Bolaños JA, Jiménez-Balderas EA, Tudón-Garcés H. Recién nacido hijo de madre toxémica. Bol Med Hosp Infant Mex 1985;42:179-187.

  7. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia: a state of sympathetic overactivity. N Engl J Med 1996;335: 1480-1485.

  8. Khatun S, Kanayama N, Sato E, Belayet HM, Kobayashi T, Terao T. Eclamptic plasma stimulates norepinephine release in cultured sympathetic nerve. Hypertension 1998;31:1343-1349.

  9. Kanayama N, Belayet HM, Khatun S, Tokunaga N, Sugimura M, Kobayashi T, Terao T. Eclamptic plasma stimulates norepinephine release in cultured sympathetic nerve. Hypertension 1998;31:1343-1349.

  10. Cruz R. Anestesia en preeclampsia-eclampsia. Preeclampsia-eclampsia. México: Distribuidora y Editora Mexicana; 2000. pp. 101-109.

  11. Ramanathan J, Coleman P, Sibai B. Anesthetic modification of hemodynamic and neuroendocrine stress responses to cesarean delivery in women with severe preeclampsia. Anesth Analg 1991;73:772-779.

  12. Grau T, Conradi R, Wacker J, Martin E. Pre-eclampsia and anesthesia. Zentralbl Gynakol 1999;121(12):627-630.

  13. Hood DD, Curry R. Spinal versus epidural anesthesia for cesarean section in severely preeclamptic patients: a retrospective survey. Anesthesiology 1999;90(5):1276-1282.

  14. Elededjam JJ, Viel E, Bruelle P, Coussaye JE. Farmacología de los anestésicos locales. En: Horay P. Enciclopedia Médico-Quirúrgica. Anestesia-Reanimación. Primera edición. París, Francia: Editions Techniques de México; 1999;Tomo I:1-15.

  15. Prys R. Farmacocinética de los anestésicos. 1ª ed. México: El Manual Moderno; 1996. pp. 139-162.

  16. Beilin Y, Zahn J, Comerford M. Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000 mm3. Anesth Analg 1997;85(2):385-388.

  17. Briones JC, Díaz-de León M, Gómez-Bravo E, Ávila F, Briones CG, Urrutia F. Protocolo de manejo en la preeclampsia-eclampsia. Estudio comparativo. Cir Ciruj 1999;67:4-10.

  18. Oates JA. Antihipertensores y la farmacoterapia de hipertensión. En: Goodman y Gilman. Las bases farmacológicas de la terapéutica. Philadelphia, PA, USA: McGraw-Hill Interamericana; 1996. pp. 835-865.

  19. Briones JC, González AR. Isoxuprina en la hipertensión del embarazo. Gac Med Mex 1997;133(5):403-406.

  20. Kanayama N, Belayet HM, Khatun S, et al. A new treatment of severe pre-eclampsia by long-term epidural anaesthesia. J Hum Hypertens 1999;13: 167-171.

  21. Richardson MG. Anestesia regional en obstetricia. Clin Anestesiol Norteamer 2000;2:371-392.

  22. Lynne AM. Trastornos Hipertensivos durante el embarazo. Clin Anestesiol Norteamer 1999;3:705-718.

  23. Horlocker TT. Complicaciones de anestesia raquídea y epidural. Clin Anestesiol Norteamer 2000;2:443-465.




2020     |     www.medigraphic.com